Telemedicine for Reach, Education, Access, and Treatment for Diabetes Self-Management Education and Support
Launched by UNIVERSITY OF PITTSBURGH · Oct 1, 2024
Trial Information
Current as of August 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Diabetes self-management education and support is considered a cornerstone of care and essential in helping people navigate self-management decisions and activities. Despite evidence that diabetes self-management education and support is a critical component of diabetes care, participation remains low. Emerging adulthood has been described as the distinct period between 18 and 25 years when adolescents work to achieve autonomy and explore life possibilities in moving toward adulthood. Suboptimal self-management has been identified as a major problem in emerging adults with type 1 diabetes, ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Diagnosed with type 1 diabetes (ICD10 E10.xx, O24.0x)
- • 18 to 25 years of age at time of study enrollment
- • Able to communicate via videoconferencing platform
- • Intending to maintain status as a patient at participating clinical sites throughout the study duration
- • Able to provide informed consent
- Exclusion Criteria:
- • Do not have a diagnosis of type 1 diabetes (ICD10 E10.xx, O24.0x)
- • Less than 18 or older than 25 years old at time of enrollment
- • Do not intend to maintain their care at participating clinical sites throughout the duration of the study
- • Are unable to communicate via telemedicine
- • Has other concerns that may interfere significantly with their ability to participate in the intervention (ongoing health issues, personal events, etc.)
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Ingrid Libman, MD, PhD
Principal Investigator
University of Pittsburgh
Linda Siminerio, RN, PhD, CDCES
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported